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Abstract
Cancer care has greatly improved
in the last few decades, as evidenced
by a 22% decline in the overall
cancer-related death rate in the
United States since 1991. However,
the question presents itself whether
rural residents, for whom the latest
advancements are not as accessible,
are also realizing these benefits as
much as their urban counterparts. The
aim of this study is to provide a
review of the literature regarding the
disparities in cancer care facing rural
Appalachia and specifically West
Virginia (WV) as well as possible
solutions towards bridging this gap.
We find that WV has a higher cancer
incidence and mortality rate with
fewer oncologists per resident, while
rural areas in general have lower
clinical trial participation and
different treatment regimens. Though
programs have been put in place such
as mobile mammography clinics and
local outreach, more work can be
done in WV in the realms of
teleoncology, virtual tumor boards,
patient support groups, and physician
training programs.

Introduction
In West Virginia (WV), the overall
cancer-related death rate from
2008-2012 was 191.1 deaths per

100,000 residents, significantly
higher than the national average
of 166.4 (Table 1).1 Though trends
suggest that overall cancer-related
death rates are falling both in WV
and nationally, the 12% relative
decline noted in WV from 1990 to
2011 lags behind the 22% national
average decline, placing it second
lowest behind Oklahoma at 9%.2
This suggests a disparity in cancer
care between WV and the nation
at-large, which has prompted
many studies examining this issue.
Furthermore, such disparities have
direct implications for WV given
that it has the third highest national
proportion of the elderly (those 65
years of age or older) at 17.3% of
its population, and the elderly tend
to have more cancer diagnoses.3 As
the segment of the aging population
continues to increase so will the
burden of cancer care in WV and the
US. In fact, by 2030, total projected
cancer incidence is estimated to
increase by roughly 45% primarily
driven by a 67% increase in
cancer diagnoses of the elderly.4

Rural Cancer Incidence
Residents of WV from 2008-2012
had age-adjusted all-site cancer
incidences of roughly 456.3 new
diagnoses per 100,000 residents
per year, which is significantly higher
than the national rate of 432.3.1
Cancer sites with significantly higher
incidence rates in WV include lung,
colorectal, bladder, kidney and
renal pelvis, and cervical cancers
(interestingly, prostate cancer had

a significantly lower incidence rate).
A variety of factors that differentiate
residents of Appalachia (defined
as regions in Alabama, Georgia,
Kentucky, Maryland, Mississippi,
New York, Ohio, Pennsylvania,
South Carolina, Tennessee, Virginia,
and all of WV) from other Americans
likely contribute, including lower
income and education levels as
well as higher rates of poor health
behaviors (ie. tobacco use).5,6
Even among their Appalachian
counterparts, WV residents have
a higher incidence of particular
cancers, such as cervical cancer.7
Environmental exposures may
play a role in increased cancer
incidence in WV, as residents of
rural counties with mountaintop
coal mining have been found to
have increased community cancer
risk.8 However, this merits more
robust study given that results of
research on this topic are mixed.9
Interestingly, when looking at
cancer incidence rates at the
county level in WV, urban counties
constitute the top three spots
and rural counties the bottom
two (using the Health Resources
Service Administration’s definition
of rural).10 Hampshire, Cabell, and
Wirt counties have the highest
incidence rates at 594.8 (95% CI:
553.7 - 638.3), 590.1 (95% CI:
569.9 - 610.9), and 572.1 (95% CI:
493.7 - 660.1) cases per 100,000
residents, whereas Doddridge
(336.7; 95% CI: 283.0 - 398.2)
and Grant (343.5; 95% CI: 303.3 387.9) counties have the lowest.11

Objectives
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1.

To describe the disparities in cancer care in West Virginia

2.

To recognize possible solutions to cancer care disparities
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Table 1
United States of
America

West Virginia

All-Site Cancer Incidence Rate

432.3

456.3

1.056 (95% CI: 1.034 - 1.079)

All-Site Cancer Mortality Rate

166.4

191.1

1.149 (95% CI: 1.011 - 1.187)

Lung and Bronchus Cancer Incidence Rate

60.4

77.1

1.278 (95% CI: 1.212 - 1.345)

Rates (per 100,000 residents)

WV / National Ratios

Lung and Bronchus Cancer Mortality Rate

45.0

59.6

1.324 (95% CI: 1.248 - 1.405)

Breast Cancer Incidence Rate

122.1

115.2

0.944 (95% CI: 0.904 - 0.985)

Breast Cancer Mortality Rate

21.3

22.3

1.047 (95% CI: 0.950 - 1.153)

Prostate Cancer Incidence Rate

105.1

90.4

0.860 (95% CI: 0.820 - 0.902)

Prostate Cancer Mortality Rate

19.6

16.0

0.807 (95% CI: 0.720 - 0.904)

Colorectal Cancer Incidence Rate

38.9

44.3

1.137 (95% CI: 1.062 - 1.219)

Colorectal Cancer Mortality Rate

14.7

17.2

1.171 (95% CI: 1.049 - 1.308)

Bladder Cancer Incidence Rate

20.2

24.5

1.213 (95% CI: 1.106 - 1.330)

Bladder Cancer Mortality Rate

4.4

4.5

1.018 (95% CI: 0.821- 1.263)

Kidney and Renal Pelvis Cancer Incidence Rate

15.8

18.7

1.182 (95% CI: 1.063 - 1.313)

Kidney and Renal Pelvis Cancer Mortality Rate

3.8

3.5

0.923 (95% CI: 0.724 - 1.178)

Cervical Cancer Incidence Rate

7.4

9.6

1.298 (95% CI: 1.120 - 1.505)

Cervical Cancer Mortality Rate

2.3

3.4

1.478 (95% CI: 1.154 - 1.895)

Figure 1

Further research is needed to
investigate the factors such as
greater amounts of air pollution that
might account for higher cancer
incidence in urban counties.

Physician Supply and
Mortality
Also of relevance to treatment of
cancer is the supply and training of
physicians. At the moment, 10% of
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physicians practice in rural areas,
and only 4.8% of newly trained
physicians are choosing to practice
in such areas.12 In WV, there are
currently 76 oncologists, which
for a population of roughly 1.85
million translates to an oncologist
density of 4.1 specialists per
100,000 residents.13 This falls on
the lower end of the rest of the
country, and of particular note is
the scarcity of cancer specialists
in many counties throughout the
state (Figure 1, Kirkwood et al.).14
The importance of physician
supply at the county-level to
cancer survival is well supported
in the literature. Aneja et al. has
found that the presence of one
radiation oncologist in a county
results in a nearly 5% decline in
prostate-cancer related deaths,15
and even more robust mortality
reductions have been noted for
esophageal (22-79%) pancreatic
(27-51%), and colorectal (12-47%)
cancers.16,17,18 The presence of
one urologist in a county also may
lead to a roughly 20% reduction in
prostate and bladder cancer-related
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deaths.19 Similar trends exist for
other cancers; for example, rural
county residence is associated
with a 5% increase in sarcomarelated mortality.20 Likewise,
residents who lived more than 50
miles away from a gynecologic
oncologist had a nearly 60% higher
risk of ovarian cancer mortality.21
Thus, the establishment of training
programs in medical oncology
and radiation oncology is key to
ensuring that an adequate cancer
workforce is available. Both West
Virginia University and Marshall
University Schools of Medicine
currently have medical oncology
fellowships, though neither at the
moment has residency programs
in radiation oncology.22,23
WV has significantly higher
mortality rates for all-sites, as well
as lung and bronchus, colorectal,
and cervical cancers. When further
examining the data by country, from
2008-2012, the top four counties with
the highest cancer-related mortality
rates per 100,000 residents were
Webster (248.3; 95% CI: 209.8292.4; urban), Wyoming (240.5;
95% CI: 215.5-268.4; rural), Lincoln
(240.5; 95% CI: 214.0-269.6; urban),
and Mingo (240.4; 95% CI: 216.0266.9; rural) counties. Those with the
lowest mortality-rates were Hardy
(151.4; 95% CI: 126.7-179.9), Grant
(129.7; 95% CI: 105.6-158.2), and
Pendleton (127.9; 95% CI: 101.0161.1) counties, all of which are
rural.2 Given that two of the top four
are urban counties, this suggests
that physician supply/proximity may
be only one of a variety of factors
that account for the higher mortality
rates observed in WV. Even so,
the effect of access to oncologists
and radiation oncologists on cancer
death rates has been supported
by many studies in the literature.

Prevention and Treatment
of Cancer in Rural America
The incidence of cancer is
generally higher in Appalachia.24
Additionally, mortality to incidence
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ratios are higher, specifically for
breast, cervical, and prostate
cancers, which some attribute
to a lack of federally qualified
health centers that provide
cancer screening.25 Lower rates
of screening in rural areas are
documented in the literature. For
example, in Kentucky, residents
of Appalachian counties were half
as likely to have a colonoscopy or
sigmoidoscopy performed within
the past 10 years as their nonAppalachian counterparts.26 As many
screenings, such as colonoscopies,
often are dependent upon physician
recommendation, it is likely that
factors such as lack of access to
primary care contribute to these
findings. This has implications for
delayed presentation and initial
staging of cancer. For example,
white and African-American women
residing in rural Mississippi were 4%
and 19% more likely, respectively,
to be diagnosed with advanced
regional/distant breast cancer
than their urban counterparts.27
Similarly, late-stage diagnosis of
melanomas is associated with areas
of lower median education levels,
as is the case in rural counties.28
Many studies have also focused
on differences in breast cancer
treatment in rural areas and
implications for survival. Freeman
et al. showed that following
surgery, early-stage breast cancer
patients in Appalachian counties of
Kentucky are less likely to receive
adjuvant radiation therapy,29 which
is associated with a 12.1% decline
in 10 year survival.30 This has been
confirmed by other studies and is
attributed to a paucity of radiation
oncologists as well as radiation
therapy facilities.31 Additionally,
patients in rural areas may be
less likely to receive adjuvant
chemotherapy. In a study of breast
cancer patients in Wisconsin having
similar likelihoods of recurrence,
Andreason et al. revealed only
36% of rural patients underwent
adjuvant chemotherapy compared
to 52% of those in urban areas.32 All
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of these factors likely contribute to
changes in breast cancer mortality
in rural areas. Though the number
of breast cancer-related deaths in
Appalachia have declined by 17.5%
from 1969-2007, this reduction is
not as robust as that observed in
non-Appalachian counties (28.3%).33
Variations in treatment
regimens for rural patients also
exist for other cancers. Notably,
retrospective studies have found
that only 46.5% of elderly lung
cancer patients in rural and
medically-underserved areas of
WV received guideline-concordant
care, which was associated
with a nearly one year decline
in survival outcomes.34 Baldwin
et al. observed that rural cases
of early-stage prostate cancers
are 3.4% less likely to receive
standard treatment regimens.35
Similarly, rural patients with stage
III colon cancer who had to travel
50 miles or greater were less likely
to receive adjuvant treatment than
those closer to treatment sites.36

Clinical Trials in Appalachia
Also of importance is whether
rural patients are given the
opportunity to participate in clinical
trials, which may provide novel
treatment strategies for cancer
sites with poorer prognoses such
as brain neoplasms and other
cancers that have progressed on
standard therapy. Prior studies
have demonstrated that areas
with higher socioeconomic levels,
approved cancer programs, and
greater oncologist density (all of
which are significantly lower in rural
Appalachia) are associated with
increased clinical trial participation.37
Furthermore, research shows that
rural residents are much less likely
to be recruited for such trials.38
There are barriers to involving
rural participants in clinical trials. A
survey of principal investigators’(PIs)
attitudes at 5 academic centers
in South Carolina found that
PIs perceive rural residents as
being the most difficult to recruit.

www.wvsma.org
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Reaching out through local doctors
for participants was not common,
and it was very uncommon to look
for other means (ie. faith-based
organizations, television, radio,
etc.) of participant recruitment.39
Furthermore, PIs perceive rural
residents as having less knowledge
and understanding of clinical trials.40
From the perspective of patients,
residents of rural areas often believe
that clinical trials are deceptive in
nature, lack general knowledge
regarding the purpose of clinical
trials, and are often dissuaded by
complicated informed consent forms.
These barriers make rural residents
less likely to participate in clinical
trials relative to urban residents.41,42

Review of Attempted
Solutions
Telemedicine, or the use of
telecommunication to provide
medical care from a distance, may
have a role in improving cancer care
in rural areas. Perhaps the most
prominent example of teleoncology

in the US is the University of Kansas
Medical Center’s (UKMC), which
reported successful implementation
of remote supervision of
chemotherapy.43 Patients come
to a local health site where a
nurse follows directions for the
physical exam from the oncologist
communicating via video. Relevant
information, such as labwork,
radiographs, etc., is then faxed to
the corresponding oncologist for
continuous review and monitoring. To
provide incentives for chemotherapy
administration, this system had
local sites collect revenues. Costs
in this model decreased with time
and steadily approached those
of traditional encounters. Patient
satisfaction from other models of
telemedicine was positive overall
following treatment.44,45 Roughly
half of patients in the UKMC study
had some concerns regarding
nurses rather than physicians
performing certain aspects of the
physical exam, though all patients
surveyed expressed satisfaction
with the model overall. Telemedicine
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may also be particularly helpful
for post-treatment follow-ups. For
example, a study done in British
Columbia, Canada, found that a
telemedicine program for colorectal
cancer patients with geographic
barriers led to a rise in the number
of follow-ups with 80% of patients
satisfied with the program.46
Of concern with telemedicine is
the safety of remotely monitoring
chemotherapy. Pathmanathan et al.
compared the incidence of adverse
effects (ie. febrile neutropenia,
diarrhea, vomiting) between rural
and urban patients in Australia with
either metastatic colorectal or nodepositive breast cancers undergoing
chemotherapy treatment over a 24
month period, and no significant
difference in the occurrence of any
side effects was noted.47 Similarly,
ambulatory cancer patients in
Singapore were monitored via a
pharmacist-run teleoncology service,
which utilized a short-messageservice algorithm to guide patients
thru a decision-making process
to provide information should a
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pharmacist not be available to talk.
This trial had 73% adherence,
and of those who completed the
service, nearly 2/3 of patients
were satisfied.48 These results
support the feasibility and safety
of chemotherapy administration
and monitoring via telemedicine.
Unlike chemotherapy, radiation
therapy is more difficult to provide
remotely given high financial
barriers to obtaining the necessary
equipment. As such, rural patients
travel to large referral centers
to receive radiation, though
telemedicine may be of use in
reducing trips for treatment planning
and simpler protocols (ie. external
beam radiation as opposed to
brachytherapy, which requires
more active surveillance). In Japan,
one study was able to accurately
transmit radiotherapy plans from a
workstation at a cancer center to
an affiliated hospital 50 km away
to allow for editing of beam data
remotely.49 Prior studies conducted
in Japan also demonstrated
accurate reproducibility of planned
isocenters (the point at which
beams of radiation converge) for
3D-conventional radiotherapy.50
Similar successful attempts at a
teleradiotherapy network were
reported in Germany for treatment
of Hodgkin’s lymphoma by means of
high-quality transfer of imaging data
and real-time teleconferences.51
Unique to cancer care,
particularly for more difficult and
rare cases, are tumor boards. Thus,
telemedicine’s application led to
the advent of virtual tumor boards
(VTBs) to allow local providers
the opportunity to consult with
specialists. As an example, the
University of North Carolina (UNC)
offered this option to community
physicians. Ninety-one percent
of participating UNC oncologists
felt that the presenting physician’s
questions were addressed and
that the information provided was
adequate for discussion, and 19%
felt that VTBs were less likely to
lead to a consensus on treatment.
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Furthermore, only 9% experienced
some sort of technology glitch
during meetings. VTBs seem
to be a viable and satisfactory
option, though noted barriers
include a lack of time for such
meetings.52 Other VTB initiatives
by Baylor and in the UK have been
implemented with high physician
satisfaction.53,54 VTBs have been
noted to increase the likelihood that
cases from community centers are
discussed at tumor boards, expedite
the process of interdisciplinary
discussion, and reduce travel
burden for rural providers.55
Telemedicine also has the
potential to improve management
of cancer-associated mental health
issues. In rural areas, patients do
not have access to support groups
or counselors. A virtual connection of
patients facing similar circumstances
to address associated symptoms
such as depression and pain
could be helpful. As an example,
a Stanford study found that breast
cancer patients in rural areas
showed significant decreases in
both depression as well as posttraumatic stress disorder (PTSD)
symptoms after participating in a
videoconference support group.56
The Indiana Cancer Pain and
Depression Trial (INCPAD) noted
similar results as patients who
received telecare management
via telephone and automated
symptom monitoring had declines
in depression and pain scores.57
Other initiatives aim at educating
providers and patients about
cancer care through developing
networks between community
stakeholders and cancer providers.
Of most relevance to WV is the
Appalachian Community Cancer
Network (ACCN), a National Cancer
Institute-designated Community
Network Program with partners
in Kentucky, Ohio, Pennsylvania,
Virginia, and WV. In WV, the ACCN
has worked closely with the Webster
County Cancer Education Project
to provide breast and cervical
cancer screening as well as the
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Wetzel County Cancer Coalition to
assist patients with transportation
for treatment.58 The network also
provides guidance, support, and
mini-grants to organizations facing
difficulty in implementing educational
interventions.59 WVU also has
a mobile mammography clinic,
which in 2009 was able to provide
360 mammograms in 20 counties
across the state, with roughly
50% of women from underserved
backgrounds, and by 2015 had
provided services to nearly 8,700
women.60,61 A statewide network has
also been established to involve
more WV residents in clinical trials.62
Outside of WV, there are other
successful rural outreach and
educational programs. Physician
awareness programs in Arkansas
have led to significant increases
in screening recommendations for
prostate, breast, and colorectal
cancers.63,64 Similarly, in Mississippi,
an educational outreach program
had 883 community volunteers
complete 16 hours of training
in cancer awareness and the
importance of clinical trials. The
volunteers also attended monthly
continuing education meetings
to disseminate information in
their respective communities
regarding screenings provided
by the state’s Department of
Health. Following the program,
pap smears increased 23% and
mammograms increased 117%.65

Conclusion
Disparities in rural Appalachia
with regards to cancer incidence,
mortality, and treatment are well
documented. To address the lack
of specialists practicing in rural
WV, a variety of education and
screening outreach programs have
been implemented and met with
success. However, other possible
solutions, notably telemedicine,
virtual tumor boards, patient support
programs, and physician training
programs in radiation oncology
have yet to be implemented or
documented in WV. Success with

www.wvsma.org

| The Elder Mountaineer: Medical Issues of an Aging Rural Population

these initiatives in areas facing
similar challenges suggests more
work can be done to bridge the gap
in cancer care for West Virginians.
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CME Post-Test
18. The all-site cancer mortality rate per 100,000
residents in WV is significantly higher than
the national average. a. True b. False

20. The oncologist density in WV is roughly 10
per 100,000 residents. a. True b. False

19. Monitoring of chemotherapy via telemedicine has
proven to be as safe as traditional encounters
in studies done thus far. a. True b. False
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